MATRIX-RARE Collaborative partners MATRIX-RARE is a national researcher-initiated clinical with participating hospitals in all Norwegian health regions.
Jabar F, Lombardi P, Torkpour A, Tafavvoghi M, Waaler PNB, Andersen S, Paulsen EE, Pøhl M, Busund LR, Donnem T, Richardsen E, Pinato DJ, Rakaee M (2026) CellPrior-net: Prior-guided nuclei detection and classification for H&E whole-slide images J Pathol Inform, 23, 100716 DOI 10.1016/j.jpi.2026.100716, PubMed 42835573 Schuster C, Oppedal IA, Vinnem LI, Abrahamsson EL, Barrett TM, Steinskog ESS, Giercksky Russnes HE, Helland Å (2026) Targeted ALK inhibition achieving tumour control in metastatic melanoma: a case report Acta Oncol, 65, 814-817 DOI 10.2340/1651-226X.2026.46424, PubMed 42820355 Nymoen HM, Zhao Z, Horndalsveen H, Bjaanæs MM, Grønberg BH, Halvorsen T, Madebo T, Aanerud M, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Alver TN, Dalen T, Öjlert ÅK, Farooqi SJ, Helland Å, Haakensen VD (2026) Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy Mol Oncol (in press) DOI 10.1002/1878-0261.70326, PubMed 42703809
